No Prescription |
 |
 | ||
|
Plavix Generic Clopidogrel bisulfate |
|
| ||
No Prescription » Prescription Drugs 13 » Plavix Generic Clopidogrel bisulfate Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Plavix keeps blood platelets slippery and discourages formation of clots thereby improving blood flow to your heart brain and body. The drug is prescribed to reduce the risk of heart attack stroke and serious circulation problems in people with hardening of the arteries or unstable angina (dangerous chest pain) and in people who've already suffered a heart attack or stroke.Clopidogrel (kloh-PID-oh-grel) is used to lessen the chance of heart attack or stroke. It is given to people who have already had a heart attack or stroke or to people with other blood circulation problems that could lead to a stroke or heart attack. Clopidogrel keeps the platelets in your blood from coagulating (clotting) to prevent unwanted blood clots that can occur with certain heart or blood vessel conditions.Clopidogrel is used to prevent blood clots after a recent heart attack or stroke and in people with certain disorders of the heart or blood vessels. Buy Plavix Generic Clopidogrel bisulfate and other Prescription Drugs 13 products online at Medstore. Buy Online at Medstore - Click Here!
About Plavix Generic Clopidogrel bisulfate: Product Type: Prescription Drugs 13 Plavix ( Generic Clopidogrel bisulfate ) Product Origin: United Kingdom Plavix (Generic Clopidogrel bisulfate) Generic Clopidogrel bisulfate 75mg Generic Clopidogrel bisulfate Plavix
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
